Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
40.01
-0.74 (-1.82%)
Jan 16, 2026, 4:00 PM EST - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $1.17 billion as of January 16, 2026. Its market cap has increased by 56.46% in one year.
Market Cap
1.17B
Enterprise Value
917.44M
1-Year Change
56.46%
Ranking
Category
Stock Price
$40.01
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $1.17B, an increase of 849.07%. That is a compound annual growth rate of 41.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.17B | 2.85% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |